BCIC生态 ｜ BCIC 获奖团队 Affinity Biopharma 完成 4 亿元人民币 B2 轮融资
祝贺 Affinity Biopharma 成功完成 4 亿元人民币（约 6,000 万美元）B2 轮融资。Affinity Biopharma 在由 Boston Chinese Investment Club (BCIC) 与 Hong Kong Science and Technology Parks Corporation (HKSTP) 联合主办的 2024 Biomedical Pitch Competition 中荣获二等奖。
http://www.affinitybiopharma.com/en/newsD-543.html
2024 Biomedical Pitch Competition 决赛获奖名单
一等奖
GV20 Therapeutics
二等奖
Affinity Biopharma
Axcynsis Therapeutics
三等奖
ImmVira Group: A Novel Payload Delivery
Rapafusyn Pharmaceuticals
Cure Genetics Inc.
D2M Biotherapeutics
Innovation Award
Leveragen, Inc.
f5 Therapeutics Incorporated
Agilis Robotics Limited
Spark Spine
Azura Bio, Inc.
AI-powered Painless Blood Test Device
NeuronOff, Inc.